MiNA Therapeutics Funding: $45M Raised, Series A (2020)
MiNA Therapeutics is based in London, United Kingdom. It has raised $45M in total funding. Latest round: Series A. Backed by Eli Lilly.
MiNA Therapeutics funding overview
MiNA Therapeutics is based in London, United Kingdom. MiNA Therapeutics has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2020. The round record for MiNA Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Eli Lilly.
MiNA Therapeutics at a glance
Total raised
$45M
Latest round
Series A
Latest round date
September 2020
Headquarters
London, United Kingdom
Notable investors
Eli Lilly
Frequently asked about MiNA Therapeutics funding
How much has MiNA Therapeutics raised?
MiNA Therapeutics has raised $45M in total disclosed funding across the rounds on record.
Who has invested in MiNA Therapeutics?
Eli Lilly are named among the investors backing MiNA Therapeutics.
What was the latest MiNA Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2020.
Where is MiNA Therapeutics based?
MiNA Therapeutics is based in London, United Kingdom.
When did MiNA Therapeutics last raise?
The last disclosed MiNA Therapeutics round closed in September 2020 at Series A.
Totals shown for MiNA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in London and the investors behind them below.
